Massachusetts Mutual Life Insurance Assigned Patent for System, Method for Ingestible Drug Delivery

ALEXANDRIA, Va., May 29 -- Massachusetts Mutual Life Insurance, Springfield, Massachusetts, has been assigned a patent (No. 11,017,892, initially filed Sept. 11, 2018) developed by two co-inventors for a "system and method for ingestible drug delivery." The co-inventors are Michal Knas, Monson, Massachusetts, and Jiby John, Suffield, Connecticut.

The full-text of the patent can be found at https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11,017,892.PN.&OS=PN/11,017,892&RS=PN/11,017,892

The abstract states: "In one embodiment of the present disclosure, an ingestible medication device is a self-contained electronic device that stores an active agent, and that controls release of the active agent using an on board processor. The ingestible medication device embodies one or more ingestible device identifiers, including personal identifiers and active agent identifiers, which are compared with external device identifiers to determine whether to release the active agent. A method for managing an ingestible medication device detects proximity to a limited range, RFID-enabled patient wristband, indicating that the wristband is worn by the patient that ingested the ingestible medication device. Various methods enable a nurse to track medication information to monitor compliance with medication regimen and dosage information. Other methods track an ingestible medication device selected for filling a prescription at a pharmacy of the health care provider, including transfer to a caregiver station using a transport cart."

Written by Ajita Mishra; edited by Sudarshan Harpal.